Actinium Pharma Revenue, Profits - ATNM Annual Income Statement

Add to My Stocks
$0.73 $0.01 (1.35%) ATNM stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the Actinium Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for ATNM which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the Actinium Pharma profit and loss statement for 2017 total to $26.84M. This line item shows that the operating expenses has increased compared with last year. Also check: Actinium Pharma assets and Actinium Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Actinium Pharma Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
Actinium Pharma Gross Profit
----------
Research & Development Expense17.69M17.5M13.31M12.26M2.66M3.44M----
Selling General & Admin Expense9.15M9.26M11.46M10.17M3.92M4.5M----
Income Before Depreciation Depletion Amortization-26.85M-26.76M-24.77M-22.44M-6.59M-7.94M-0.01M-0.02M-0.01M-0.02M
Depreciation Depletion Amortization----------
Non Operating Income-2.53M3.81M-2.2M-4.17M-----
Interest Expense-0.01M----1.09M----
Actinium Pharma Pretax Income
-26.6M-24.32M-21.02M-24.68M-10.77M-8.36M---0.02M-0.03M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-26.6M-24.32M-21.02M-24.68M-10.77M-8.36M---0.02M-0.03M
Extraordinary Items & Discontinued Operations----------
Actinium Pharma Profit/ Loss (Net Income)
-26.6M-24.32M-21.02M-24.68M-10.77M-8.36M---0.02M-0.03M
Average Shares used to compute Diluted EPS-48.46M38.16M27.36M------
Average Shares used to compute Basic EPS-48.46M38.16M27.36M------
Income Before Nonrecurring Items--24.32M-21.03M-24.69M------
Income from Nonrecurring Items----------
Actinium Pharma Earnings Per Share Basic Net
-0.39-0.50-0.55-0.90------
Actinium Pharma Earnings Per Share Diluted Net
--0.50-0.55-0.90------
EPS Diluted Before Nonrecurring Items--0.50-0.55-0.90------
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Actinium Pharma stock analysis are:

  • Topline: A growing topline, as seen from the Actinium Pharma revenue chart, as isn't the case with Actinium Pharma indicates a sagging business. One needs to compare the YoY topline or sales growth of ATNM stock with its peers like ELTP stock and CPHR stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-26.6M for ATNM stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The ATNM financials along with Actinium Pharma historical stock prices provide a lot of details about the firm.

Actinium Pharma Income Statement - Key Financial Ratios